19th Annual IMS Meeting
The 19th Annual International Myeloma Society (IMS) Meeting took place from August 25-27. Topics covered at the meeting included disease monitoring, high-risk multiple myeloma, induction for newly diagnosed myeloma, relapsed multiple myeloma, immune constitution and vaccination, and cellular therapies.
Advertisement
Advertisement
Doris Hansen, MD, of the Moffitt Cancer Center, spoke about the research during an oral abstract presentation at IMS.
Adding a monoclonal antibody to a triplet treatment significantly lowered the risk of disease...
A single infusion of ciltacabtagene autoleucel “resulted in deep and durable responses" in CARTITUDE-2’s cohort A.
The data were from the phase III DETERMINATION trial...
Carfilzomib, lenalidomide, and dexamethasone improved progression-free survival (PFS) over...
Adding ixazomib to pomalidomide and dexamethasone improved progression-free survival rates...
Blood Cancers Today delivers the latest news, education, and information relevant to hematologic oncology patients and practices.
Sign up to receive Blood Cancers Today eNewsletters:
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.